RLAY Competitors & Alternatives
Compare Relay Therapeutics Inc with similar stocks in the same industry
Biotechnology
RLAY
Main Stock$19.44
Tradestie Score
53
Market Cap
$917.23M
Revenue Growth
-0.5%
Analyst Upside
+39.3%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PCVX
Vaxcyte, Inc. Common Stock
|
$62.62
|
$4.94B | - | 30 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$69.82
|
$4.93B | - | 54 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$87.11
|
$4.84B | - | 50 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$154.32
|
$3.98B | 153.4 | 43 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$84.69
|
$3.92B | - | 40 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$119.80
|
$3.91B | - | 38 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$26.01
|
$3.83B | - | 33 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$17.00
|
$3.68B | - | 51 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$96.31
|
$3.67B | - | 66 | Compare |
More RLAY Analysis
Data updated: Aug 22, 2026 | Industry: Biotechnology (SIC 2836)
237 stocks in this industry